Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

We have observed 64 EP applications Jane Harriet Evenson has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12774724

ANTIBODIES AND OTHER MOLECULES THAT BIND B7-H1 AND PD-1

IPC classification:
A61K 39/395, C07K 16/28, C07K 16/30
Applicant:
MedImmune, LLC
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Multiple attorneys, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP12797228

TREATMENT OF FRATAXIN (FXN) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO FXN

IPC classification:
C12N 15/113
Applicant:
CuRNA, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12804033

SIGNATURES AND DETERMINANTS ASSOCIATED WITH PROSTATE CANCER PROGRESSION AND METHODS OF USE THEREOF

IPC classification:
C12Q 1/68, G01N 33/574
Applicant:
Dana-Farber Cancer Institute, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13178039

Process for preparing maytansinoid antibody conjugates

IPC classification:
A61K 47/48
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12829528

TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES

IPC classification:
A61K 31/00, A61K 38/00
Applicant:
CuRNA, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12744250

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

IPC classification:
A61K 31/20, A61K 31/4015, A61P 25/28
Applicant:
Johns Hopkins University
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14163759

Methods for producing prepartions of recombinant AAVvirions substantially free of empty capsids

IPC classification:
B01D 15/00, B01D 15/04, C02F 1/42, C12N 7/02, C12N 15/864
Applicant:
Genzyme Corporation
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12856692

USE OF N-HYDROXYSUCCINIMIDE TO IMPROVE CONJUGATE STABILITY

IPC classification:
A61K 39/395
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP12842601

METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS

IPC classification:
A61K 38/18, A61P 7/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13707529

ANTI SEZ6 ANTIBODIES AND METHODS OF USE

IPC classification:
C07K 16/28
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13772302

METHODS AND COMPOSITIONS FOR INCREASING RED BLOOD CELLS

IPC classification:
A61K 38/19, A61P 7/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13744924

XYLOSE ISOMERASES AND THEIR USES

IPC classification:
C12N 9/90, C12N 15/10, C12P 7/10
Applicant:
BP Corporation North America Inc.
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13765550

BIOTIN COMPLEXES FOR TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE

IPC classification:
A61K 31/713, A61P 25/28, C12N 15/11, C12N 15/113
Applicant:
Massachusetts General Hospital
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15154800

Inhibition of complement C5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection

IPC classification:
A61K 39/00, A61K 39/395, A61P 37/06, C07H 21/04, C07K 16/18, C12N 5/12, C12N 15/12
Applicant:
Genentech, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14195878

Notch1 receptor binding agents and methods of use thereof

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13771732

PEPTIDE-LINKED MORPHOLINO ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF MYOTONIC DYSTROPHY

IPC classification:
C12N 15/113
Applicant:
Genzyme Corporation
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13843881

USE OF AN ION EXCHANGE MEMBRANE TO REMOVE IMPURITIES FROM CELL-BINDING AGENT CYTOTOXIC AGENT CONJUGATES

IPC classification:
A23J 1/10, A61K 47/48, C07K 16/46
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13844268

USE OF A PVDF MEMBRANE TO PURIFY CELL-BINDING AGENT CYTOTOXIC AGENT CONJUGATES

IPC classification:
B01D 39/14, C12M 1/12
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12705776

NOVEL MODULATORS AND METHODS OF USE

IPC classification:
C07K 16/30
Agent:
John William Graham Jappy, Gill Jennings & Every LLP
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13854262

METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA

IPC classification:
A61K 31/445, A61K 31/55, A61K 31/662
Applicant:
Johns Hopkins University
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14704011

ANTI-TNF AND ANTI-IL17 COMBINATION THERAPY BIOMARKERS FOR INFLAMMATORY DISEASE

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
AbbVie Inc
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14749020

NOVEL MULTISPECIFIC CONSTRUCTS

IPC classification:
C12N 15/13
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15169743

HUMAN MONOCLONAL ANTIBODIES TO ACTIVIN RECEPTOR-LIKE KINASE-1

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/40, C12N 5/12, C12N 15/13
Applicant:
Pfizer Inc
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14779587

METHODS OF DETECTING CANCER

IPC classification:
G01N 33/00, G01N 33/574
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14764293

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

IPC classification:
A61K 31/13
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14765419

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

IPC classification:
A61K 31/19
Applicant:
Johns Hopkins University
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14773017

MET-BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18, C12P 21/08
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15185710

TREATMENT OF 'C TERMINUS OF HSP70-INTERACTING PROTEIN' (CHIP) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO CHIP

IPC classification:
A61K 31/7088, A61K 48/00, A61P 25/00, A61P 37/00, C12N 15/113
Applicant:
CuRNA, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15176887

ALK7 POLYPEPTIDES FOR USE IN PROMOTING FAT LOSS

IPC classification:
A61K 38/17, A61P 21/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15178099

COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER

IPC classification:
A61K 39/395, A61P 35/00, C07K 14/475, C07K 14/705, C07K 16/28, C12N 15/12
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15198284

COMPOSITIONS OF TUMOR SPECIFIC NEOANTIGENS

IPC classification:
A61K 39/395, A61P 35/00, C07K 7/06, C07K 14/47, C12Q 1/68, G01N 33/50, G01N 33/53, G01N 33/68
Applicant:
Massachusetts General Hospital
Applicant:
Dana-Farber Cancer Institute, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Robert Charles Dempster, Maschio & Soames IP Limited
Status:
EXAMINATION IN PROGRESS
EP16152143

INHIBITION OF COMPLEMENT C5 ACTIVATION FOR THE TREATMENT AND PREVENTION OF DELAYED XENOGRAFT OR ACUTE VASCULAR REJECTION

IPC classification:
A61K 39/00, A61K 39/395, A61P 37/06, C07H 21/04, C07K 16/18, C12N 5/12, C12N 15/12
Applicant:
Genentech, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15189425

ISOLATION AND PURIFICATION OF ANTI-IL-13 ANTIBODIES USING PROTEIN A AFFINITY CHROMATOGRAPHY

IPC classification:
A61K 39/395, C07K 16/06, C07K 16/24
Applicant:
AbbVie Inc
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14839285

SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/00, C12P 21/08
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14839261

ENGINEERED ANTI-DLL3 CONJUGATES AND METHODS OF USE

IPC classification:
A61K 47/48
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14839298

NOVEL SEZ6 MODULATORS AND METHODS OF USE

IPC classification:
A61K 38/00, A61K 39/395, A61P 35/00, C07K 16/28
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14837885

TGF-BETA RECEPTOR TYPE II VARIANTS AND USES THEREOF

IPC classification:
A61K 38/16, A61P 9/10, A61P 35/00, C07K 14/475, C07K 16/22, C07K 19/00
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14821379

FORMULATIONS FOR NEOPLASIA VACCINES

IPC classification:
A61K 39/00
Applicant:
The Broad Institute, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14870710

BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT

IPC classification:
C07D 237/26
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14874789

IMMUNOTHERAPY WITH BINDING AGENTS

IPC classification:
C07K 16/28
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16164549

ANTI DLL3 ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61K 47/48, A61P 35/00, C07K 14/47, C07K 16/28, C07K 16/30
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP16164551

DLL3 MODULATORS AND METHODS OF USE

IPC classification:
A61K 47/48, A61P 35/00, C07K 14/47, C07K 16/28, C07K 16/30
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP16164567

ANTI DLL3 ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61K 47/48, A61P 35/00, C07K 14/47, C07K 16/28, C07K 16/30
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15752054

ANTI-DLL3 ANTIBODIES AND DRUG CONJUGATES FOR USE IN MELANOMA

IPC classification:
A61K 39/395, A61K 47/48, G01N 33/574
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15758330

METHODS FOR TREATING CANCER WITH NOTCH1 ANTIBODIES

IPC classification:
A61K 39/395, C12Q 1/68, G01N 33/574
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16186033

COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS

IPC classification:
A61K 38/00, A61P 7/06, C07K 14/71
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP15765863

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS BY INHIBITING ACTIVIN B AND/OR GDF11

IPC classification:
A61K 31/7088, A61K 38/18, A61K 39/395, A61P 7/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15779814

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING SICKLE-CELL DISEASE

IPC classification:
A61K 38/17, A61K 38/18, A61P 7/06, C07K 16/22, C07K 16/46
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15785217

POLYFLUORINATED COMPOUNDS ACTING AS BRUTON'S TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/519, A61P 1/04, A61P 3/10, A61P 5/20, A61P 21/04, A61P 37/02, C07C 43/29, C07C 45/29, C07C 49/813, C07C 303/38, C07C 311/08, C07D 213/81, C07D 215/22, C07D 215/233, C07D 239/34, C07D 487/04, C07D 519/00, C07F 5/04
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15806256

METHODS AND COMPOSITIONS FOR TREATING ULCERS

IPC classification:
A61K 38/18, A61K 39/395, A61P 17/02, C07K 19/00
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15802909

METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS WITH FOLLISTATIN POLYPEPTIDES

IPC classification:
A61K 38/16, A61P 21/06, C07K 19/00, C12N 15/62
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15837897

NOVEL ANTI-MFI2 ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 45/00, C07K 16/18, C12P 21/08
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP15775545

USE OF CLONAL EVOLUTION ANALYSIS FOR IBRUTINIB RESISTANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

IPC classification:
C12Q 1/68
Applicant:
Harvard College
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP15847978

HIV VACCINES COMPRISING ONE OR MORE POPULATION EPISENSUS ANTIGENS

IPC classification:
A61K 39/21, A61P 31/18
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP16195379

ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF FOR REGULATING BODY FAT CONTENT

IPC classification:
A61K 31/663, A61K 38/17, A61K 38/18, A61P 19/08, A61P 19/10, A61P 21/00, C07K 14/705, A61K 47/51
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
The application has been published
EP15854065

METHODS AND COMPOSITIONS USING GDF15 POLYPEPTIDES FOR INCREASING RED BLOOD CELLS

IPC classification:
A61K 38/18, A61P 7/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP15857690

ANTI-CLDN CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE

IPC classification:
A61P 35/00, C07K 14/725, C07K 16/28
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP15865103

METHODS FOR TREATING MYELODYSPLASTIC SYNDROMES AND SIDEROBLASTIC ANEMIAS

IPC classification:
A61K 38/18, A61K 39/395, A61P 7/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP15828435

METHODS FOR PROFILING THE T-CELL-RECEPTOR REPERTOIRE

IPC classification:
A61K 35/17, A61K 39/00, C12N 15/10
Applicant:
Massachusetts General Hospital
Applicant:
Dana-Farber Cancer Institute, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP17159235

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASE SECONDARY TO MULTIPLE SCLEROSIS

IPC classification:
C12Q 1/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
The application has been published
EP15832934

MOLECULAR BIOMARKERS FOR CANCER IMMUNOTHERAPY

IPC classification:
C12Q 1/68, G01N 33/574
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Applicant:
Massachusetts General Hospital
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP16747162

TNFRSF-BINDING AGENTS AND USES THEREOF

IPC classification:
C07H 21/04, C07K 14/00, C12N 15/00, C12N 15/19, C12N 15/62, C12Q 1/68
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP16756219

ANTI-DLL3 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE

IPC classification:
A61K 35/12, A61K 35/14, A61K 38/00
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP16759572

ENGINEERED SITE-SPECIFIC ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, A61K 47/48, C07K 16/28
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made

Please Sign in to use this feature